Immunogenetics and the design of Plasmodium falciparum vaccines for use in malaria-endemic populations.
Plebanski
Magdalena
M
Vaccine Development and Infectious Diseases Unit, The Austin Research Institute, A & RMC Hospital Campus, Heidelberg, Victoria, Australia. mplebans@ari.unimelb.edu.au
Proudfoot
Owen
O
Pouniotis
Dodie
D
Coppel
Ross L
RL
Apostolopoulos
Vasso
V
Flannery
Graham
G
D000818:Animals; D000913:Antibodies, Protozoan / Q000276:immunology; D017951:Antigen Presentation / Q000276:immunology; D005075:Biological Evolution; D018955:CD36 Antigens / Q000276:immunology; D016207:Cytokines / Q000276:immunology; D019353:Endemic Diseases; D006801:Humans; D007110:Immunity, Active / Q000276:immunology; D007113:Immunity, Innate / Q000276:immunology; D007125:Immunogenetics; D018799:Intercellular Adhesion Molecule-1 / Q000276:immunology; D017780:Malaria Vaccines / Q000276:immunology*; D016778:Malaria, Falciparum / Q000276:immunology / Q000517:prevention & control*; D010963:Plasmodium falciparum / Q000235:genetics / Q000276:immunology*; D011961:Receptors, Fc / Q000276:immunology
D000913:Antibodies, Protozoan; D018955:CD36 Antigens; D016207:Cytokines; D017780:Malaria Vaccines; D011961:Receptors, Fc; D018799:Intercellular Adhesion Molecule-1